[HTML][HTML] A quantitative multimodal metabolomic assay for colorectal cancer
F Farshidfar, KA Kopciuk, R Hilsden, SE McGregor… - BMC cancer, 2018 - Springer
Background Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
[PDF][PDF] A quantitative multimodal metabolomic assay for colorectal cancer
F Farshidfar, KA Kopciuk, R Hilsden, SE McGregor… - 2018 - prism.ucalgary.ca
Background: Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
A quantitative multimodal metabolomic assay for colorectal cancer
F Farshidfar, KA Kopciuk, R Hilsden… - BMC …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
A quantitative multimodal metabolomic assay for colorectal cancer.
F Farshidfar, KA Kopciuk, R Hilsden, SE McGregor… - BMC Cancer, 2018 - europepmc.org
Background Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
A quantitative multimodal metabolomic assay for colorectal cancer
F Farshidfar, KA Kopciuk, R Hilsden, SE McGregor… - BMC Cancer, 2018 - go.gale.com
Background Colorectal cancer (CRC) is the third most common cause of cancer death
worldwide. Early diagnosis is important, as early disease is curable [1-3] and management …
worldwide. Early diagnosis is important, as early disease is curable [1-3] and management …
[HTML][HTML] A quantitative multimodal metabolomic assay for colorectal cancer
F Farshidfar, KA Kopciuk, R Hilsden… - BMC …, 2018 - bmccancer.biomedcentral.com
Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves treatment
outcomes. We previously described a diagnostic metabolomic biomarker derived from semi …
outcomes. We previously described a diagnostic metabolomic biomarker derived from semi …
[HTML][HTML] A quantitative multimodal metabolomic assay for colorectal cancer
F Farshidfar, KA Kopciuk, R Hilsden, SE McGregor… - BMC Cancer, 2018 - ncbi.nlm.nih.gov
Background Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
[PDF][PDF] A quantitative multimodal metabolomic assay for colorectal cancer
F Farshidfar, KA Kopciuk, R Hilsden, SE McGregor… - 2018 - bmccancer.biomedcentral.com
Background: Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
[PDF][PDF] A quantitative multimodal metabolomic assay for colorectal cancer
F Farshidfar, KA Kopciuk, R Hilsden, SE McGregor… - 2018 - prism.ucalgary.ca
Background: Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
A quantitative multimodal metabolomic assay for colorectal cancer.
F Farshidfar, KA Kopciuk, R Hilsden, SE McGregor… - BMC Cancer, 2018 - europepmc.org
Background Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …
treatment outcomes. We previously described a diagnostic metabolomic biomarker derived …